AMPHION INNOVAT. LS -,01
[WKN: A0J2VM | ISIN: GB00B0DJNP99]
Aktienkurse
Echtzeit-Aktienkurs AMPHION INNOVAT. LS -,01
Bid: Ask:

Echtzeit-Chart der AMPHION INNOVAT. LS -,01 Aktie

AMPHION INNOVAT. LS -,01 Chart

Charttool öffnen

Fundamentaldaten der AMPHION INNOVAT. LS -,01 Aktie

Income Statement: 10-Year-Summary

Datum Umsatz EBIT Gewinn EPS Dividende KGV KUV
2017 [GBP] -2,24 Mio. 1,94 Mio. 1,94 Mio. 0,01 - - -
2016 [GBP] 0,58 Mio. -12,48 Mio. -12,48 Mio. -0,07 - - -
2015 [GBP] 2,16 Mio. 3,89 Mio. 3,89 Mio. 0,02 - - -
2014 [GBP] 0,82 Mio. -7,65 Mio. -7,65 Mio. -0,06 - - -
Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet.

Weitere Informationen

Profil der AMPHION INNOVAT. LS -,01 Aktie

Amphion Innovations plc is a principal investment firm specializing in both public and private early stage investments and spun out of universities and corporations. It does not invest in “speculative� technologies requiring long development timeframes or excessive capital investment. It invests in the medical, life sciences, and technology sectors with defensible core intellectual property, know-how and growth potential in very large markets of at least $1 billion in size together with corporations, governments, universities, and entrepreneurs. The firm typically invests in companies with broad-based, proprietary, platform technologies in the areas of pharmacogenomics, proteomics, nutriceuticals or wellness, diagnostics, medical products and related fields, leveraging advances in and the convergence of materials science and life science IT, particularly software technologies. It targets investments in companies based in both the United States and United Kingdom. The firm makes inv